These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 3842636)
61. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer. Berry J Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441 [TBL] [Abstract][Full Text] [Related]
62. The nature of tamoxifen action in the control of female breast cancer. Kodama M; Kodama T In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224 [TBL] [Abstract][Full Text] [Related]
63. Adjuvant endocrine therapy for early breast cancer: the story so far. Gradishar WJ Cancer Invest; 2010 May; 28(4):433-42. PubMed ID: 20307199 [TBL] [Abstract][Full Text] [Related]
64. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer]. Tuxen MK; Nielsen DL; Lindberg H; Kamby C Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922 [TBL] [Abstract][Full Text] [Related]
65. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview. Sliwińska M; Wojtacki J; Sliwiński W Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346 [TBL] [Abstract][Full Text] [Related]
66. Myelosuppression occurring after receiving tamoxifen for breast cancer. International Adjuvant Therapy Organisation. Br J Radiol; 1985 Dec; 58(696):1220. PubMed ID: 3842636 [No Abstract] [Full Text] [Related]
67. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma]. Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764 [TBL] [Abstract][Full Text] [Related]
68. Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer. Case report and review of the literature. Lauro S; Lalle M; D'Andrea MR; Vecchione A; Frati L Anticancer Res; 1994; 14(5B):2171-2. PubMed ID: 7840519 [TBL] [Abstract][Full Text] [Related]
69. [Tamoxifen in breast cancer: viewpoint of the gynecologist]. De Muylder X Acta Clin Belg; 1992; 47(3):178-84. PubMed ID: 1332348 [TBL] [Abstract][Full Text] [Related]
70. Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women. Gradishar WJ Oncology; 2005; 69(1):1-9. PubMed ID: 16088229 [TBL] [Abstract][Full Text] [Related]
71. Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer. Jordan VC Annu Rev Pharmacol Toxicol; 1995; 35():195-211. PubMed ID: 7598491 [TBL] [Abstract][Full Text] [Related]